Funding for this research was provided by:
The Japan Agency for Medical Research and Development (22rea522104h0001)
Received: 7 February 2023
Accepted: 4 September 2023
First Online: 12 September 2023
: The study was conducted in accordance with the Declaration of Helsinki, and approved by the ethics committee of Osaka Center for Cancer and Cardiovascular Diseases Prevention (Project registration code: R4-Rinri-4). To obtain consent on this study, opt-out method was performed by using the poster description (posted inside the facility of Osaka Center for Cancer and Cardiovascular Diseases Prevention) and institutional website later. Participants had the option to opt out of the study after viewing study information shared via poster (posted inside the facility) and institutional website. This website is available at: ExternalRef removed (accessed on 20 July 2022).
: Not applicable.
: The authors declare that they have no competing interests.